GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocGo Inc (NAS:DCGO) » Definitions » Altman Z2-Score

DocGo (DCGO) Altman Z2-Score : 5.46 (As of Mar. 26, 2025)


View and export this data going back to 2021. Start your Free Trial

What is DocGo Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

DocGo has a Altman Z2-Score of 5.46, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for DocGo's Altman Z2-Score or its related term are showing as below:

DCGO' s Altman Z2-Score Range Over the Past 10 Years
Min: 0.62   Med: 5.46   Max: 6.77
Current: 5.46

During the past 6 years, DocGo's highest Altman Z2-Score was 6.77. The lowest was 0.62. And the median was 5.46.


DocGo Altman Z2-Score Historical Data

The historical data trend for DocGo's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocGo Altman Z2-Score Chart

DocGo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Altman Z2-Score
Get a 7-Day Free Trial 0.62 6.77 5.51 4.04 5.46

DocGo Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.04 4.66 4.92 5.05 5.46

Competitive Comparison of DocGo's Altman Z2-Score

For the Medical Care Facilities subindustry, DocGo's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocGo's Altman Z2-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocGo's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where DocGo's Altman Z2-Score falls into.


';

DocGo Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

DocGo's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.4009+3.26*-0.0031+6.72*0.0651+1.05*2.2851
=5.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2024:
Total Assets was $455.6 Mil.
Total Current Assets was $304.5 Mil.
Total Current Liabilities was $121.8 Mil.
Retained Earnings was $-1.4 Mil.
Pre-Tax Income was -6.575 + 9.034 + 9.567 + 15.722 = $27.7 Mil.
Interest Expense was -0.541 + -0.505 + -0.514 + -0.369 = $-1.9 Mil.
Total Liabilities was $140.4 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(304.486 - 121.807)/455.621
=0.4009

X2=Retained Earnings/Total Assets
=-1.402/455.621
=-0.0031

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(27.748 - -1.929)/455.621
=0.0651

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(320.917 - 0)/140.442
=2.2851

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

DocGo has a Altman Z2-Score of 5.46 indicating it is in Safe Zones.


DocGo  (NAS:DCGO) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


DocGo Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of DocGo's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


DocGo Business Description

Traded in Other Exchanges
N/A
Address
685 Third Avenue, 9th Floor, New York, NY, USA, 10017
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
Executives
Etalvina Leite director 5477 VIA NICOLA, NEWBURY PARK CA 91320
Ely D Tendler director, officer: General Counsel, Secretary STRATEGIC AND LEGAL SERVICES, PLLC, 54 LAWRENCE AVENUE, LAWRENCE NY 11559
Michael J Burdiek director 39 PARKER, IRVINE CA 92618
Lee Bienstock officer: Chief Operating Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Steven Katz director 20 REBEL RUN DR, EAST BRUNSWICK NJ 08816
Norman Rosenberg officer: CFO, Ambulnz Holdings, LLC 51 MOUNTAIN AVENUE, MONSEY NY 10952
Stephen Sugrue officer: Chief Compliance Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Anthony Capone officer: President 106 DUANE ST., #3, NEW YORK NY 10007
Adriaan Stephanus Oberholzer officer: Chief Financial Officer 35 W 35TH STREET, 6TH FLOOR, NEW YORK NY 10001
James M Travers director C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Stanley Vashovsky director, 10 percent owner, officer: Chief Executive Officer 763 RALEIGH STREET, WOODMERE NY 11598
Ira Smedra director 401 N. JUNE STREET, LOS ANGELES CA 90004
Mark Do Merlin officer: CMO, Ambulnz Holdings, LLC 35 W 35TH STREET, NEW YORK NY 10001
Michael S. Witkowski officer: Chief Compliance Officer PO BOX 10482, NEWBURGH NY 12552
Christopher Fillo director 3110 MAIN STREET, SUITE 310, SANTA MONICA CA 90405